His primary areas of study are Immunology, Internal medicine, Myositis, Polymyositis and Dermatomyositis. Immunoglobulin G and Genetic enhancement is closely connected to Virology in his research, which is encompassed under the umbrella topic of Immunology. His Internal medicine research includes themes of Gastroenterology, Autoantibody and Weakness.
His work deals with themes such as Autoimmunity, Myocarditis and Myopathy, which intersect with Myositis. His Polymyositis research incorporates themes from Inflammation, Hepatitis B, Physical therapy and CD8. Olivier Benveniste combines subjects such as Interferon type I, Cancer research, Downregulation and upregulation and Myogenesis with his study of Dermatomyositis.
The scientist’s investigation covers issues in Immunology, Internal medicine, Myositis, Pathology and Dermatomyositis. His Immunology study is mostly concerned with Antibody, Autoantibody, Immune system, Inflammation and Cytokine. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Surgery.
His studies deal with areas such as Arthritis, Myocarditis, Lung and Rheumatology as well as Myositis. Pathology is closely attributed to Muscle weakness in his study. His work is dedicated to discovering how Dermatomyositis, Polymyositis are connected with Pathogenesis and other disciplines.
His primary scientific interests are in Internal medicine, Myositis, Dermatomyositis, Autoantibody and Immunology. In most of his Internal medicine studies, his work intersects topics such as Gastroenterology. Myositis is a subfield of Pathology that Olivier Benveniste tackles.
His Pathology research is multidisciplinary, incorporating elements of Muscular dystrophy and Immune system. His Autoantibody research integrates issues from Polymyositis, Weakness and Sub classification. Immunology and Mass cytometry are frequently intertwined in his study.
Internal medicine, Myositis, Autoantibody, Dermatomyositis and Pathology are his primary areas of study. His Internal medicine study incorporates themes from Gastroenterology and Rituximab. Olivier Benveniste is involved in the study of Myositis that focuses on Inclusion body myositis in particular.
His Autoantibody study improves the overall literature in Immunology. He has researched Dermatomyositis in several fields, including Interferon type I, Retrospective cohort study, Antisynthetase syndrome and Myogenin. His research in Pathology intersects with topics in Muscular dystrophy and Immune system.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors.
Sylvie Boutin;Virginie Monteilhet;Philippe Veron;Christian Leborgne.
Human Gene Therapy (2010)
Long-term observational study of sporadic inclusion body myositis
Olivier Benveniste;Marguerite Guiguet;Jane Freebody;Odile Dubourg.
Brain (2011)
Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.
Baptiste Hervier;Hervé Devilliers;Raluca Stanciu;Alain Meyer.
Autoimmunity Reviews (2012)
Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.
Yves Allenbach;Laurent Drouot;Aude Rigolet;Jean Luc Charuel.
Medicine (2014)
Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular dystrophy.
Norma B. Romero;Serge Braun;Olivier Benveniste.
Human Gene Therapy (2004)
Correlation of anti–signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy
Olivier Benveniste;Laurent Drouot;Fabienne Jouen;Jean-Luc Charuel.
Arthritis & Rheumatism (2011)
High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.
Yves Allenbach;Jeremy Keraen;Anne-Marie Bouvier;Valérie Jooste.
Brain (2016)
Mechanisms Involved in the Low-Level Regeneration of CD4+ Cells in HIV-1—Infected Patients Receiving Highly Active Antiretroviral Therapy Who Have Prolonged Undetectable Plasma Viral Loads
Olivier Benveniste;Antoine Flahault;Florence Rollot;Carole Elbim.
The Journal of Infectious Diseases (2005)
Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis.
Benjamin Terrier;Guillaume Geri;Wahiba Chaara;Yves Allenbach.
Arthritis & Rheumatism (2012)
Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer
Mehdi Touat;Thierry Maisonobe;Samuel Knauss;Omar Ben Hadj Salem.
Neurology (2018)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Université Paris Cité
Université Paris Cité
Université Paris Cité
University of Lille
Université Paris Cité
Karolinska University Hospital
University College London
Université Paris Cité
Université Paris Cité
University of Strasbourg
National University of Singapore
University of Pittsburgh
University of Padua
California Institute of Technology
University of Wrocław
City University of Hong Kong
Mines ParisTech
Centers for Disease Control and Prevention
Emory University
National Center for Toxicological Research
Utrecht University
The Open University
California Institute of Technology
Cornell University
University of California, San Francisco
National Institutes of Health